Announcement

Collapse
No announcement yet.

Pricing for AMX0035 (Ambrioza) in Canada

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Pricing for AMX0035 (Ambrioza) in Canada

    Back in June, Health Canada conditionally approved ALBRIOZA for use in Canada. It is now commercially available, but there are still negotiations going on regarding how the costs will be covered.

    The Canadian Agency for Drugs and Technologies in Health has released reimbursement recommendations today.

    https://www.cadth.ca/sites/default/f...meqO7kgSMeMfzS Qafo56mbwav7TZzoNpkd14YmDla3lms

    This is a link to the pdf of their report if anyone is interested in reading it.

    Copied from table 3, regarding treatment cost, “The annual cost of PB-TURSO, as calculated by CADTH, was $217,459 in the first year of treatment and $223,900 in subsequent years.”

    This assumes the patient is also on Riluzole or Edaravone. I’m at a loss for words.
    Diagnosed December 2020 with lower limb onset ALS, now involving hands and arms.

    #2
    That's roughly £140,000, year 1, £144,200pa thereafter, in case you're wondering.
    ​Diagnosed 03/2007. Sporadic Definite ALS/MND Spinal (hand) Onset.
    Eye gaze user - No functional limbs - No speech - Feeding tube - Overnight NIV.

    Comment

    Working...
    X